ArticleThe American journal of gastroenterology2018

Defining an Optimal Adherence Threshold for Patients Taking Subcutaneous Anti-TNFs for Inflammatory Bowel Diseases.

Shail M Govani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.